Provention Bio Inc (PRVB)

$24.98 0.00 (0.00%)

16:00 EDT PRVB Stock Quote Delayed 30 Minutes

Why Is Provention Bio (PRVB) Stock Up 263% Today?

By William White, InvestorPlace Writer Mar 13, 2023

Provention Bio (PRVB) stock is rocketing higher on Monday following news that Sanofi (SNY) is acquiring the company for $2.9 billion.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Provention Bio (PRVB) Stock Falls Despite FDA Approval

Why Is Provention Biosciences (PRVB) Stock Up 25% Today?

More Articles

Volume:

Previous Close -

Market Cap 2.37B

PE Ratio -62.45

EPS -0.4

Volume (Avg. Vol.)

Day's Range -

52-Week Range $24.98 - $24.98

Dividend & Yield N/A (N/A)

PRVB Stock Predictions, Articles, and Provention Bio Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jan 28, 2022

Good morning, investor! The week is almost done but we're not slacking as we check out the biggest pre-market stock movers for Friday!

7 Biotech Stocks to Buy That Have Millionaire-Maker Potential

By Josh Enomoto, InvestorPlace Contributor Sep 10, 2021

This sector is always a risky area to gamble in. If you have the stomach for it, however, these biotech stocks could see massive gains.

3 Biotech Stocks Ready for Big Breakthroughs Like Biogen

By Muslim Farooque, InvestorPlace Contributor Jun 24, 2021

This could be a breakthrough year for these three biotech stocks, resulting in massive gains for their stockholders similar to Biogen.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Friday Morning

By William White, InvestorPlace Writer Apr 9, 2021

The end of the week is quickly approaching but investors can't relax yet and we're here to help with Friday's biggest pre-market movers.

5 Hot Insider Trading Stocks to Buy Under $10

By Harriet Lefton, Writer, TipRanks Sep 2, 2019

Buying stocks that insiders are trading is one good strategy. These five stocks with high levels of insider trading are good buys, and cheap.

Provention Bio News: Why PRVB Stock Is Skyrocketing Today

By William White, InvestorPlace Writer Jun 10, 2019

Provention Bio news about one of the company's drugs has PRVB stock heading higher Monday on positive results from a recent study.

Provention Bio gains after HSR waiting period for Sanofi deal expired (NASDAQ:PRVB)

From Seeking Alpha Apr 26, 2023

Provention Bio (PRVB) rose 3.1% in premarket trading after the HSR antitrust waiting period for the company's sale to Sanofi (SNY) expired

Is Sanofi Stock a Buy Now?

From The Motley Fool Mar 25, 2023

The pharma giant has outperformed the broader market over the past 12 months.

Why Provention Bio Stock Skyrocketed 256% This Week

From The Motley Fool Mar 16, 2023

Provention Bio is currently a partner of Sanofi. It should soon become a part of the big French drugmaker.

Why Shares of MacroGenics Climbed Thursday

From The Motley Fool Mar 16, 2023

The cancer-focused biotech delivered a strong earnings report.

Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners

From The Motley Fool Mar 13, 2023

On a volatile market day, companies are still looking for smart combinations.

Hot Stocks: ZIM, ZYXI rise; PRVB, SGEN jumps on M&A deal; ILMN, up; ZEV, FRC, SCHW slide

From Seeking Alpha Mar 13, 2023

Stocks see-sawed during Monday#39;s intraday trading as investors weighed a proposal to backup all of the depositors in the defunct Silicon Valley Bank.Looking at the specific stocks that...

ADVERTISEMENT